Exponent, Inc. (NASDAQ:EXPO) Q4 2025 Earnings Call Transcript February 5, 2026 Exponent, Inc. beats earnings expectations.
StockStory.org on MSN
Exponent’s (NASDAQ:EXPO) Q4 CY2025: Strong sales
Scientific consulting firm Exponent (NASDAQ:EXPO) reported in Q4 CY2025, with sales up 19.1% year on year to $147.4 million. Its GAAP profit of $0.49 per share was 3.7% above analysts’ consensus ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results